IFNG and schizophrenia: However, T cells of patients with schizophrenia exhibit decreased production of IFN-γ (Arolt et al., 2000), and the IFN-γ inducer Anaferon improved outcomes in schizophrenia therapy (Vetlugina et al., 2016).